Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.39
Delayed Data
As of Mar 27
 -0.005 / -0.36%
Today’s Change
1.19
Today|||52-Week Range
2.09
-0.36%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.39
Today’s open1.39
Day’s range1.36 - 1.40
Volume865,378
Average volume (3 months)1,301,140
Market cap$260.8M
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-36.36%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales10.03
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc+0.08+1.27%
VVUSVIVUS Inc+0.08+3.21%
NAVBNavidea Biopharmaceu...+0.03+1.82%
SNTASynta Pharmaceutical...0.000.00%
Data as of 4:06pm ET, 03/27/2015

Financials

Next reporting dateJuly 13, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account